| Ytd | -37.47% | |
| 1y | -53.04% |
| Open | 5.50 | Prev Close | 5.49 | Low | 5.50 | High | 5.99 | Mkt Cap | 9.57M |
| Vol | 8.65K | Avg Vol | 10.21K | EPS | -0.34 | P/E | -17.03 | Forward P/E | -5.64 |
| Beta | 1.06 | Short Ratio | 2.34 | Inst. Own | 6.08% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-14 | 50-d Avg | 8.28 | 200-d Avg | 11.31 | 1yr Est | 10.00 |
LEXX News
Kelowna, British Columbia – TheNewswire - July 30, 2026 – Lexaria Bioscience Corp. (Nasdaq: LEXX) (t
KELOWNA, BC / ACCESS Newswire / July 30, 2026 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (the "Company
Gainers ENDRA Life Sciences (NASDAQ:NDRA) shares rose 10.8% to $5.94 during Tuesday's after-mar
Lexaria Bioscience (NASDAQ:LEXX) reported quarterly losses of $(0.08) per share which beat the analy
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-mark
Kelowna, British Columbia – July 6, 2026 – TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX) (th
KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company"
Kelowna, British Columbia – June 25, 2026 - TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX) (t
KELOWNA, BC / ACCESS Newswire / June 25, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company
Potentially valuable novel compositions being investigated Lexaria also receives additional new gran
Potentially Valuable Novel Compositions Being Investigated Lexaria Also Receives Additional New Gran
More people than ever taking GLP-1 drugs for weight loss Growing list of diseases now indicated as t
More People Than Ever Taking GLP-1 Drugs for Weight Loss Growing List of Diseases Now Indicated as T
Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary Dehydr
Retatrutide and amycretin are being investigated for compatibility with Lexaria's proprietary Dehydr
KELOWNA, BC / ACCESS Newswire / June 3, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or
Kelowna, British Columbia - June 3 , 2026 – TheNewswire - Lexaria Bioscience Corp. (NASDAQ: LEXX) (“
KELOWNA, BC / ACCESS Newswire / May 19, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or
CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Res
CEO Rich Christopher Discusses Recently Announced Material Transfer Agreement Extension and 2026 Res
KELOWNA, BC / ACCESS Newswire / May 5, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) ("Lexaria" or t
Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity an
Inaugural Episode Features CEO Rich Christopher on DehydraTECH Platform, GLP-1 Market Opportunity, a
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 100 po
Gainers Indaptus Therapeutics (NASDAQ: INDP) stock moved upwards by 108.1% to $6.83 during Friday&#
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 250 points on Fri
Gainers
On Monday, 85 stocks hit new 52-week lows.
On Tuesday, 164 companies hit new 52-week lows.
Friday's session saw 100 companies set new 52-week lows.
On Thursday, 498 companies reached new 52-week lows.
Gainers
Gainers Qilian International Holding Group Ltd (NASDAQ: QLI) shares jumped 76.2% to $8.81 after t